FFMI: A Pivotal Indicator Bridging Pulmonary, Sleep, and Systemic Factors in COPD-OSA Overlap Patients

Area of Science:

• Pulmonary Medicine
• Sleep Medicine
• Clinical Nutrition

Background:

• Overlap Syndrome (OVS), a combination of Chronic Obstructive Pulmonary Disease (COPD) and Obstructive Sleep Apnea (OSA), is prevalent but frequently underdiagnosed.
• Understanding the distinct physiological characteristics of OVS is crucial for effective patient management.

Purpose of the Study:

• To compare the Fat-Free Mass Index (FFMI) between patients with OVS and those with COPD alone.
• To analyze differences within OVS subgroups based on FFMI for improved early identification and severity assessment.

Main Methods:

• Analysis of clinical data from 364 patients (203 COPD, 161 OVS).
• Comparison of pulmonary function, sleep apnea indices, and body composition (FFMI) between groups.
• Subgroup analysis of OVS patients based on FFMI (cutoff < 17kg/m²).

Main Results:

• OVS patients exhibited significantly lower FEV1%pred, FEV1/FVC, 6MWT, FFMI, and L-SaO2 compared to COPD patients (p < 0.05).
• OVS patients also showed higher AHI, ESS, CAT, and MMRC scores.
• Lower FFMI in OVS subgroups correlated with poorer lung function, lower L-SaO2, reduced 6MWT, and increased exacerbation/hospitalization frequency (p < 0.05).

Conclusions:

• OVS presents with distinct clinical features, including more frequent exacerbations and diminished lung function.
• FFMI serves as a significant indicator, closely related to pulmonary function, sleep disorder severity, and exacerbation rates in OVS.
• FFMI holds potential for early OVS detection and evaluating disease severity.